Advances in Metabonomics and Its Applications

Abstract

Abstract: Metabonomics(or metabolomics)is an essential part of systems biology. Through the study of metabolic changes inorganisms, their physiological and biochemical status can be known and the internal principle can be discovered. The meaning and research taskof metabonomics were introduced in this paper. Generation, technological platform of metabonomics and its application in plants, microorganisms,disease diagnosis and toxicology were summarized. A review on the development trend and challenges were also given.

Key words: Metabonomics , Nuclear magnetic resonance , Systems biology , Proteomics , Data analysis

Zhou QiuxiangYu Xiaobin, Tu Guoquan, Wang Qiang, Hu Wenjun, Li Hanguang^{1, 3}. Advances in Metabonomics and Its Applications[J]. Biotechnology Bulletin, 2013, 0(1): 49-55.

References

[1] Krastanov A. Metabolomics-the state of art[J]. Biotechnol andBiotechnol, 2010, 24（1）：1537-1543.
[2] Karl HO, Nelly A, Singh B, et al. Metabonomics classifies pathwaysaffected by bioacfive compounds. Artificial neural network classificationof NMR spectra of plant extracts[J]. Phytochemistry, 2003,62 ：971-985.
[3] Fiehn O. Metabolomics-the link between genotypes and phenotypes[J]. Plant Mol Biol, 2002, 48（1-2）：155-171.
[4] Lindon JC, Holmes E, Bolland ME, et al. Metabonomics technologiesand their applications in physiological monitoring, drug safety assessmentand disease diagnosis[J]. Biomarkers, 2004, 9（1）：1-31.
[5] Nicholson JK, Lindon JC, Holmes E. “Metabonomics”：understandingthe metabolic responses of living systems to pathophysiological stimulivia multivariate statisstical analysis of biological NMR spectroscopicdata[J]. Xenobiotica, 1999, 29（11）：1181-1189.
[6] Vander GJ, Leegwater DC. Urine profile analysis by field desorptionmass spectrometry, a technique for detecring metabolites of xenobiotics.Application to 3, 5-dinitro-2-hydroxy toluene[J]. BiomedMass Spectrom, 1983, 10（1）：1-4.
[7] Preeti B, Stephanie M, Moon KH, et al. PlantMetabolomics.org ：AWeb Portal for Plant Metabolomics Experiments[J]. Plant Physiol,2010, 152 ：1807-1816.
[8] Dettmer K, Hammock BD. Metabolomics—A new exciting fieldwithin the “omics” sciences[J]. Environ Health Perspect, 2004,112（7）：A396-A397.
[9] Taylor J, Buckingham MJ, Sadler PJ. Application of metabolomicsto plant genotype discrimination using statistics and machine learning[J]. Bioinforrnatics, 2002, 18 ：241-248.
[10] Jan S. Application of NMR in plant metabolomics ：Techniques,生物技术通报 Biotechnology Bulletin 2013年第1期54problems and prospects[J]. Phytochem Anal, 2010, 21 ：14-21.
[11] Konstantina S, Lan D, Wilson, et al. HILIC-UPLC-MS for exploratoryurinary metabolic profiling in toxicological Studies[J].Anal Chem, 2011, 83, 382-390.
[12] Oakman C, Tenoril C, Biganzoli L, et al. Uncovering the metabolomicfingerprint of breast cancer[J]. Internationa Journal of Biochemistryand Cell Biology, 2010, 43（7）：1010-1020.
[13] Ott KH, Aranibar N. Nuclear magnetic resonance metabonomics ：methods for drug discovery and development[J]. Methods MolBiol, 2007, 358 ：247-271.
[14] Rooney OM, Troke J, Nicholson JK, et al. High-resolution diffusionand relaxation-edited magic angle spinning 1H NMR spectroscopyof intact liver tissue[J]. Magn Reson Med, 2003, 50（5）：925-930.
[15] Wishanrt DS. Quantitative metabolomics using NMR[J]. Trendsand Chem, 2008, 27（3）：228-237.
[16] Krone N, Hughes BA, Lavery GG, et al. Gas chromatogmphy/massspectrometry（GC/MS）remains a preeminent discovery tool in clinicalsteroid investigations even in the era of fast liquid chromatographytandem mass spectrometry（LC/MS/MS）[J]. J Steroid BiochemMol Biol, 2010, 121（3-5）：496-504.
[17] Drexler DM, Reily MD, Shipkova PA. Advances in massspectrometryapplied to pharmaceutical metabolomics
[J/OL]. Anal BioanalChem, 2010, 399（8）：2645-2653.
[18] Styczynski MP, Moxley JF, Tong LV, et al. Systematic identificationof conserved metabolites in GC/MS data for metabolomics andbiomarker discovery[J]. Anal Chem, 2007, 79（3）：966-973.
[19] Liu L, Moxley JF, Tong LV, et al. Differences in metabolite profilebetween blood plasma and serum[J]. Anal Biochem, 2010, 406（2）：105-112.
[20] Wei J, Xie GX, Zhou ZT, et al. Salivary metabolite signatures oforal cancer and leukoplakia[J]. Int J Cancer, 2011, 129（9）：2207-2217.
[21] Holmes E, Antti H. Chemometric contributions to the evoluttion ofmetabonomics mathematical solutions to characterising and interpretingcomplex biological NMR spectra[J]. Analyst, 2002, 27（12）：1549-1557.
[22] Keun HC, Bbels TMD, Bollard ME, et al. Geometric trajectoryanalysis of metabolic responses to toxicity can define reatmentspecific profiles[J]. Chem Res Toxicol, 2004, 17（5）：579-587.
[23] Wang C, Kong HW, Guan YF, et al. Plasma phospholipid metabolicprofiliing and biomarkers of type 2 diabetes mellitus based on highperformanceliquid chromatography/electrospray mass spectrometryand multivariate statistical analysis[J]. Anal Chem, 2005, 77（13）：4108-4116.
[24] Sun JC, Von LS, Tungeln W, et al. Identification of metaboliteprofiles of the catechol-O-methyl transferase inhibitor tolcaponein rat urine using LC-MS-based metabonomics analysis[J].Chromatorgraph B-Analyt Technol Biomed Life Sci, 2009, 877（24）：2557-2565.
[25] Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics[J]. J Pmteome Res, 2007, 6（2）：469-479.
[26] Lindon JC, Holmes E, Nicholson JK. Toxicological applicationssofmagnetic resonace[J]. Prog NMR Spectr, 2004, 45（1-2）：109-143.
[27] Bundy JG, Lenz EM, Bailey NJ, et al. Metabonomic assessmentof toxicity of 4-fluoroaniline, 3, 5-difluoroaniline and 2-fluoro-4-methylaniline to the earthworm Eisenia veneta（Rosa）：identification of new endogenous biomarkers[J]. EnvironmToxicol Chem, 2002, 21（9）：1966-1972.
[28] Nicholson JK, Timbrell JA, Higham DP, et al. Mercury and cadmiumnephrotoxic and the detection of abnomal urinary metabolites by protonNMR-spectroscopy[J]. Human Toxicol, 1984, 3（4）：334-335.
[29] Nicholson JK, Timbrell JA, Sadler PJ, et al. Proton NMR-spectra ofurine as indicators of renal damage-mercury-induced nephrotoxicityin RATS[J]. Mol Pharmacol, 1985, 27（6）：644-651.
[30] Stewart JD, Bolt HM. Metabolomics ：biomarkers of diease anddrug toxicity[J]. Arch Toxicol, 2011, 85 ：3-4.
[31] Kleno TG, Kiehr B, Baunsgaard D, et al. Combination of “omics”data to investigate the mechanism（s）of hydrazine-induced hepatotoxicityin rats and to identify potential biomarkers[J]. Biomarkers,2004, 9（2）：116-138.
[32] Schnackenberg L, Beger RD, Dragan Y, et al. NMR-based metabonomicevaluation of livers from rats chronically treated with tamoxifen,mestranol and phenobarbital[J]. Metabolomics, 2005, 1（10）：87-94.
[33] Ma C, Bi K, Zhang M, et al. Toxicology effects of morning gloryseed in rat ：a metabonomic method forprofiling of urine metabolic2013年第1期55 周秋香等：代谢组学研究进展及其应用changes[J]. Journal of Ethnopharmacology, 2010, 130（1）：134-142.
[34] Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosisof the presence and severity of coronary heart disease using1H-NMR-based metabonomics[J]. Nat Med, 2002, 8（12）：1439-1444.
[35] Wu DJ, Zhu BJ, Wang XD. Metabonomics-based omics study andatherosclerosis[J]. Journal of Clinical Bioinformatics, 2011, 1 ：30.
[36] Shang Q, Xiang JF, Tang YL. NMR-based metabonomics ：a usefulplatform of oncology reseatch[J]. Bioanal Rev, 2010, 1 ：117-140.
[37] Sabatille MS, Liu E, Morrow DA, et al. Metabolomic identificationof novel biomarkers of myocardial ischemia[J]. Cireulation,2005 ：112（25）：3868-3875.
[38] Peng JB, Jia HM, Xu T, et al. A 1H NMR based metabonomicsapproach to progression of coronary atherosclerosis in a rabbitmodel[J]. Process Biochemistry, 2011, 46（12）：2240-2247.
[39] Li x, Yang SB, Qiu YP, et al. Urinary metabolomics as a potentiallynovel diagnostic and stratification tool for knee osteoarthritis[J].Metabolomics, 2010, 6 ：109-118.
[40] Sun LY, Hu WH, Liu Q, et al. Metabonomics reveals plasma metabolicchanges and inflammatory marker in polycystic ovary syndromepatients[J]. J Proteome Res, 2012, 11（5）：2937-2946.
[41] Arora DK. Fungal biotechnology in agricultura1, food and environmentalapplications[M]. New York ：Marcel Dekker, 2004 ：19-35.
[42] Bundy JG, Willey TL, Castell RS, et al. Discrimination ofpathogenic clinical isolates and laboratory strains of Bacillus cereusby NMR-based metabolomic profiling[J]. FEMS MicrobiolLetters, 2005, 242（1）：127-136.
[43] Buchholz A, Hurlebaus J, Wandrey C, et al. Metabolomies ：quantification of intracellular metabolite dynamics[J]. BiomolEng, 2002, 19 ：5-15.
[44] Dalluge JJ, Smith S, Sanchez-Riera F, et al. Potential of fermentationprofiling via rapid measurement of amino acid metabolism by liquidchromatography-tandem mass spectrometry[J]. Chromatography,2004, 1043（1）：3-7.
[45] Raamsdonk LM, Teusink B, Broadhurst D, et al. A Functionalgenomics strategy that uses metabolome data to reveal thephenotype of silent mutations[J]. Nat Biotechnol, 2011, 19（1）：45-50.
[46] Sumner LW, Mendes P, Dixon RA. Plant metabolomies ：largescalephytoehemistry in the functional genomics era[J]. Phytochemistry,2003, 62 ：817-836.
[47] Hye KK, Young HC, Robert V, et al. NMR-based metabolomicanalysis of plants[J]. Nature Protocols, 2010, 5 ：536-549.
[48] Humphreys JM, Chapple C. Rewriting the lignin roadmap. CurrentOpinion in Plant[J]. Biology, 2002, 5 ：224-229.
[49] Fraser PD, Pinto MES, Holloway DE, et al.Application of highperformanceliquid chromatography with photodiode array detectionto the metabolic profiling of plant isoprenoids[J]. Plant Journal,2000, 24（4）：551-558.
[50] Atsushi I, Fumio M, Hisashi M, et al. Metabolomics for metabolicallymanipulated plants ：effects of tryptophan overproduction[J]. Metabolomics, 2007, 3 ：319-334.